According to an FDA warning letter, the agency found problems with microbial contamination in an inspection of the CMO's New Jersey facility earlier this year, affecting DPT's Santyl Ointment ...

to collagenase SANTYL ointment, approved by the FDA for debriding chronic dermal ulcers. SANTYL is currently the market-leading enzymatic debridement product, with more than $360 million in estimated ...